麦默通系统在乳腺占位性病变中的诊疗作用  

Application of Mammotome System in Diagnosis and Therapy of Breast Masses

作　　者：杨桦[1] 李顺荣[1] 萧俏珍[1] 苏逢锡[1] 

机构地区：[1]中山大学附属第二医院南院乳腺肿瘤中心,广东省广州市510260

出　　处：《中国全科医学》2009年第21期1973-1974,1977,共3页Chinese General Practice

摘　　要：目的探讨超声引导下麦默通系统在乳腺占位性病变中的诊疗作用。方法选择2006年9月—2008年12月我科收治的931例患者,术前均经超声确诊为乳腺实性占位性病变,利用麦默通系统行微创手术。结果931例患者均完整切除病灶,良性病变920例(98.8%),恶性病变11例(1.2%),恶性病变确诊后均行保乳手术或改良根治术。术后并发症:血肿23例(2.5%),皮肤青紫78例(8.4%)。术后超声随访,3例复发,均为良性,复发率为0.3%。结论超声引导下的麦默通系统在乳腺良性病变的治疗中具有安全、有效、微创、美观的特点,值得临床推广。对于临床不可触及或多发,同时可疑恶性的病灶,利用麦默通系统的活检功能可以准确定位,明确诊断,并及时给予适当的后续治疗。Objective To investigate the value of ultrasound-guided Mammotome system in the diagnosis and therapy of breast masses. Methods From September 2006 to December 2008, 931 inpatients were diagnosed breast masses by ultrasonogpaphy before surgery and they undergone Mammotome biopsy. Results The masses of 931 patients were excised completely. The breast masses of 920 patients （98.8%） were benign, and of 11 patients （1.2%） were malignant. All the patients with malignant masses received breast conservation therapy or modified radical mastectomy. The surgical complications were hematoma in 23 patients （2.5%） and petechia in 78 patients （8.4%）. All the patients were followed up by ultrasonography, and only 3 benign cases （0.3%） ware found.Conclusion Ultrasound-guided Mammotome system for breast benign lesions is safe, effective and minimally-invasive, with good appearance of the operated areas. It is worth popularizing clinically. For those clinical multiple or nonpalpable and suspicious malignant lesions, the lesions can be correctly located and diagnosed by using this system and thus the patients can get suitable subsequent therap.

关 键 词：乳腺疾病 超声引导 麦默通系统 

分 类 号：R655.8[医药卫生—外科学]